Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Change in Account Payables (2016 - 2017)

Rocket Pharmaceuticals' Change in Account Payables history spans 2 years, with the latest figure at $15000.0 for Q3 2017.

  • For Q3 2017, Change in Account Payables fell 98.25% year-over-year to $15000.0; the TTM value through Sep 2017 reached -$1.4 million, changed N/A, while the annual FY2017 figure was -$1.1 million, 2682.93% down from the prior year.
  • Change in Account Payables for Q3 2017 was $15000.0 at Rocket Pharmaceuticals, up from -$1.5 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $856000.0 in Q3 2016 and bottomed at -$1.5 million in Q2 2017.